Followers | 504 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Tuesday, November 17, 2015 9:48:39 AM
bearish 7.75
## source: finance.yahoo.com
Tue, 10 Nov 2015 19:10:07 GMT ~ Avalanche (AAVL) Reports Wider-than-Expected Loss in Q3
read full: http://finance.yahoo.com/news/avalanche-aavl-reports-wider-expected-191007558.html
*********************************************************
Mon, 09 Nov 2015 21:29:43 GMT ~ AVALANCHE BIOTECHNOLOGIES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statemen
read full: http://biz.yahoo.com/e/151109/aavl8-k.html
*********************************************************
Mon, 09 Nov 2015 21:26:18 GMT ~ Avalanche Biotechnologies, Inc. Reports Third Quarter 2015 Financial Results
[at noodls] - MENLO PARK, Calif., Nov. 9, 2015 (GLOBE NEWSWIRE) -- Avalanche Biotechnologies, Inc. (Nasdaq:AAVL), a biopharmaceutical company committed to improving or preserving the sight of people suffering from serious ...
read full: http://www.noodls.com/view/7BA8C0F3832BA4190C0E90DCA89F85CD858F833E
*********************************************************
Mon, 09 Nov 2015 21:05:00 GMT ~ Avalanche Biotechnologies, Inc. Reports Third Quarter 2015 Financial Results
[GlobeNewswire] - MENLO PARK, Calif. -- Avalanche Biotechnologies, Inc. , a biopharmaceutical company committed to improving or preserving the sight of people suffering from serious eye diseases with an unmet medical need, ...
read full: http://finance.yahoo.com/news/avalanche-biotechnologies-inc-reports-third-210500549.html
*********************************************************
Thu, 05 Nov 2015 21:19:06 GMT ~ AVALANCHE BIOTECHNOLOGIES, INC. Files SEC form 8-K, Other Events
read full: http://biz.yahoo.com/e/151105/aavl8-k.html
*********************************************************
$AAVL charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$AAVL company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/AAVL/company-info
Ticker: $AAVL
OTC Market Place: Not Available
CIK code: not found
Company name: Avalanche Biotechnologies, Inc.
Incorporated In:
$AAVL share structure
## source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$AAVL extra dd links
Company name: Avalanche Biotechnologies, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/AAVL/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/AAVL/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=AAVL+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=AAVL+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=AAVL+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/AAVL/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/AAVL/news - http://finance.yahoo.com/q/h?s=AAVL+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/AAVL/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/AAVL/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/AAVL/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/AAVL/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/AAVL/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/AAVL/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/AAVL/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/AAVL/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=AAVL+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/AAVL
DTCC (dtcc.com): http://search2.dtcc.com/?q=Avalanche+Biotechnologies%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Avalanche+Biotechnologies%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Avalanche+Biotechnologies%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/AAVL/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/AAVL
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/AAVL/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/AAVL/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/AAVL/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/AAVL/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/AAVL/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/AAVL/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/AAVL/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=AAVL&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=AAVL
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/AAVL/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=AAVL+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=AAVL+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=AAVL
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=AAVL
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=AAVL+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/AAVL/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=AAVL+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/AAVL.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=AAVL
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/AAVL/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/AAVL/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/AAVL/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/AAVL/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/AAVL
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/AAVL
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/AAVL:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=AAVL
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=AAVL
$AAVL DD Notes ~ http://www.ddnotesmaker.com/AAVL
Recent ADVM News
- Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 09/05/2024 11:30:00 AM
- Adverum Biotechnologies to Participate in Upcoming Fall Investor Conferences • GlobeNewswire Inc. • 09/04/2024 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 08:10:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 08:08:24 PM
- Adverum Biotechnologies Reports Second Quarter 2024 Financial Results and Provides Program and Corporate Highlights • GlobeNewswire Inc. • 08/12/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:10:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:09:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 08:09:00 PM
- Adverum Biotechnologies to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference • GlobeNewswire Inc. • 08/02/2024 11:00:00 AM
- Adverum Biotechnologies Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted for Ixo-vec for the Treatment of Wet AMD • GlobeNewswire Inc. • 08/01/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2024 08:38:02 PM
- Adverum Biotechnologies Presents Positive Ixo-vec Clinical Data from the 26-Week Interim Analysis of the LUNA Phase 2 Trial at the 2024 ASRS Annual Meeting • GlobeNewswire Inc. • 07/17/2024 06:45:00 AM
- Adverum Biotechnologies to Host Webcast to Review Clinical Data from the 26-Week Interim Analysis of the Ongoing LUNA Phase 2 Trial in Wet AMD Being Presented at ASRS Annual Meeting • GlobeNewswire Inc. • 07/10/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 08:07:03 PM
- Adverum Biotechnologies to Participate in TD Cowen’s Genetic Medicines & RNA Summit • GlobeNewswire Inc. • 06/18/2024 12:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/11/2024 08:19:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2024 08:16:53 PM
- Adverum Biotechnologies Announces Appointments of Dr. Rabia Gurses Ozden as Chief Medical Officer and Dr. Szilárd Kiss as a Member of the Board of Directors • GlobeNewswire Inc. • 06/11/2024 12:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/28/2024 06:00:14 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:13:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:10:27 PM
- Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlights • GlobeNewswire Inc. • 05/09/2024 08:05:00 PM
- Adverum Biotechnologies to Participate in Upcoming May Investor Conferences • GlobeNewswire Inc. • 05/03/2024 12:00:00 PM
- Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientific Meeting • GlobeNewswire Inc. • 04/25/2024 08:05:00 PM
- Adverum Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Pipeline Highlights and Corporate Updates • GlobeNewswire Inc. • 03/18/2024 08:05:00 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM